Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone‐sensitive prostate cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of early abiraterone acetate in combination with androgen deprivation therapy for newly diagnosed metastatic hormone‐sensitive prostate cancer.

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cochrane Database Syst Rev
Egile Nagusiak: Sathianathen, Niranjan J, Dahm, Philipp, Brown, Sarah Jane, Oestreich, Makinna, Gupta, Shilpa, Konety, Badrinath R, Kunath, Frank
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2019
Gaiak:
Medicine General & Introductory Medical Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6353243/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013245
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak